Considerations for Waiver Requests for pH Adjusters in Generic Drug Products Intended for Parenteral, Otic, and Ophthalmic Use; Draft Guidance for Industry; Availability

1 organizations filed 1 public comment on Considerations for Waiver Requests for pH Adjusters in Generic Drug Products Intended for Parenteral, Otic, and Ophthalmic Use; Draft Guidance for Industry; Availability, at the Food and Drug Administration. The comment window closed 1506d ago.

Commenters (1)

• Association for Accessible Medicinestrade assoc.

  1 filing · confidence 97%